Vaziri N D, Liang K H
Department of Medicine, University of California, Irvine, USA.
Kidney Int. 1995 Dec;48(6):1979-85. doi: 10.1038/ki.1995.500.
Increased production and depressed catabolism of lipoproteins play major roles in the pathogenesis of hypercholesterolemia of nephrotic syndrome (NS). However, the effect, if any, of NS on cholesterol biosynthetic capacity is uncertain. We examined the gene expression of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoAR, the rate limiting step in cholesterol biosynthesis) during the induction and chronic phase of puromycin (PAN)-induced NS in rats. The rats were randomized to NS (given i.p. puromycin aminonucleoside 130 mg/kg on day 1 and 60 mg/kg on day 14) and placebo-treated control groups. Subgroups of animals were sacrificed at days 5, 10, 20 and 30. The liver was harvested between 7 and 9 p.m. for measurements of HMG-CoAR and actin mRNAs, HMG-CoAR enzymatic activity and microsomal cholesterol concentration. In separate experiments, subgroups of animals with chronic NS (day 30) were studied in fed and 20-hour fasting states. A marked but transient rise in hepatic HMG-CoAR mRNA and HMG-CoAR enzymatic activity was observed following the onset and exacerbation of proteinuria within a few days after each puromycin injection. On each occasion, HMG-CoAR fell to the baseline level despite persistent severe hypercholesterolemia. In an attempt to examine the possible acute effect of PAN per se, experiments were repeated before and at short intervals (8 and 24 hr) after puromycin injection when proteinuria was absent and the drug exposure prominent. The HMG-CoAR mRNA and activity were virtually unchanged during this period, suggesting the lack of an acute effect of puromycin. Twenty-hour fasting led to a marked rise in HMG-CoAR mRNA and activity in animals with chronic NS but not in the controls. Microsomal cholesterol remained unchanged and comparable in the two groups at all points. Thus, the marked but transient rise in hepatic HMG-CoAR gene expression observed during the induction phase and with fasting during the chronic phase of PAN-induced NS may contribute to the generation and maintenance of hypercholesterolemia in this animal model.
脂蛋白生成增加和分解代谢受抑制在肾病综合征(NS)高胆固醇血症的发病机制中起主要作用。然而,NS对胆固醇生物合成能力的影响(如果有)尚不确定。我们研究了大鼠嘌呤霉素(PAN)诱导的NS诱导期和慢性期肝脏3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoAR,胆固醇生物合成的限速步骤)的基因表达。将大鼠随机分为NS组(第1天腹腔注射嘌呤霉素氨基核苷130mg/kg,第14天注射60mg/kg)和安慰剂治疗对照组。在第5、10、20和30天处死动物亚组。晚上7点到9点采集肝脏,用于测量HMG-CoAR和肌动蛋白mRNA、HMG-CoAR酶活性和微粒体胆固醇浓度。在单独的实验中,对慢性NS(第30天)动物亚组在进食和禁食20小时状态下进行研究。每次注射嘌呤霉素后几天内,随着蛋白尿的出现和加重,观察到肝脏HMG-CoAR mRNA和HMG-CoAR酶活性显著但短暂升高。每次都是这样,尽管持续存在严重的高胆固醇血症,HMG-CoAR仍降至基线水平。为了研究PAN本身可能的急性作用,在嘌呤霉素注射前和注射后短时间间隔(8和24小时)重复实验,此时无蛋白尿且药物暴露明显。在此期间,HMG-CoAR mRNA和活性几乎没有变化,表明嘌呤霉素缺乏急性作用。禁食20小时导致慢性NS动物肝脏HMG-CoAR mRNA和活性显著升高,但对照组没有。两组微粒体胆固醇在所有时间点均保持不变且相当。因此,在PAN诱导的NS诱导期和慢性期禁食期间观察到的肝脏HMG-CoAR基因表达显著但短暂升高可能有助于该动物模型中高胆固醇血症的产生和维持。